Travel-Related Infections

Emergency Medicine Clinics of North America

Volumn 26, Issue 2, 2008, Pages 499-516

  House, Hans R ^a   Ehlers, Jesmin P ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMOXICILLIN; ATOVAQUONE; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CHLOROQUINE; CIPROFLOXACIN; DEXAMETHASONE; DIETHYLTOLUAMIDE; DOXYCYCLINE; MEFLOQUINE; OSELTAMIVIR; PENICILLIN G; PRIMAQUINE; PROGUANIL; QUINIDINE GLUCONATE; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIMANTADINE; STIBOGLUCONATE SODIUM; TETRACYCLINE; VANCOMYCIN; ZANAMIVIR;

AFRICAN TRYPANOSOMIASIS; AVIAN INFLUENZA; CARIBBEAN ISLANDS; CHOLERA; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; DENGUE; DIZZINESS; EMERGENCY WARD; ENDEMIC DISEASE; EPIDEMIC MENINGITIS; FOOD CONTAMINATION; FOOD INTAKE; HEPATITIS A; HUMAN; INFECTION; INFECTION RISK; INSECT BITE; INSOMNIA; LARVA MIGRANS; LEISHMANIASIS; LEPTOSPIROSIS; LYME DISEASE; MALARIA; PLASMODIUM; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; RICKETTSIA; RICKETTSIOSIS; RISK FACTOR; SINGLE DRUG DOSE; TRAVEL; TRAVELLER DIARRHEA; TYPHOID FEVER; VACCINATION; WATER CONTAMINATION; YELLOW FEVER;

EID: 41749102912     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.01.008     Document Type: Review

References (54)

1. Freedman D.O., Weld L.H., Kozarsky P.E., et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354 2 (2006) 119-130
2. Hill D.R. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 7 (2000) 259-266
3. Steffen R., deBernardis C., and Banos A. Travel epidemiology-a global perspective. Int J Antimicrob Agents 21 (2003) 89-95
4. Leder K., Tong S., Weld L., et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 43 9 (2006) 1185-1193
5. Wilson M.E., Weld L.H., Boggild A., et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 44 12 (2007) 1560-1568
6. Ryan E.T., Wilson M.E., and Kain K.C. Illness after international travel. N Engl J Med 347 (2002) 505-516
7. Doherty J.F., Grant A.D., and Bryceson A.D. Fever as the presenting complaint of travelers returning from the tropics. QJM 88 4 (1995) 277-281
8. Askling H.H., Nilsson J., Tegnell A., et al. Malaria risk in travelers. Emerg Infect Dis 11 3 (2005) 436-441
9. Jelinek T., Schulte C., Behrens R., et al. Imported falciparum malaria in Europe: sentinel surveillance data from the European Network on Surveillance of Imported Infectious Diseases. Clin Infect Dis 34 (2002) 572-576
10. Phillips-Howard P.A., Radalowicz A., Mitchell J., et al. Risk of malaria in British residents returning from malarious areas. BMJ 300 (1990) 499-503
11. Lengeler C. Insecticide treated bednets and curtains for preventing malaria. Cochrane Infectious Diseases Group. The Cochrane Library, Issue 1 (2007), John Wiley & Sons, Chichester (UK) [search date 2003]
12. Soto J., Medina F., Dember N., et al. Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers. Clin Infect Dis 21 (1995) 599-602
13. Rowland M., Downey G., Rab A., et al. DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan. Trop Med Int Health 9 (2004) 335-342
14. Centers for Disease Control. Treatment of malaria. Available at: www.cdc.gov. Accessed October 15, 2007.
15. Zucker J.R., and Campbell C.C. Malaria: principles of prevention and treatment. Infect Dis Clin North Am 7 3 (1993) 547-567
16. Jelinek T. Dengue fever in international travelers. Clin Infect Dis 31 (2000) 144-147
17. Wilder-Smith A., and Schwartz E. Dengue in travelers. N Engl J Med 353 (2005) 924-932
18. Jensenius M., Fournier P.E., and Raoult D. Tick-borne rickettsioses in international travellers. Int J Infect Dis 8 3 (2004) 139-146
19. Lucchina L.C., Wilson M.E., and Drake L.A. Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations. Int J Dermatol 36 3 (1997) 167-181
20. Gelman S.S., Gundlapalli A.V., Hale D., et al. Spotting the spirochete: rapid diagnosis of leptospirosis in two returned travelers. J Travel Med 9 3 (2002) 165-167
21. Lo Re III V., and Gluckman S.J. Fever in the returned traveler. Am Fam Physician 68 7 (2003) 1343-1350
22. Sagliocca L., Amoroso P., Adamo B., et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection. Lancet 353 9159 (1999) 1136-1139
23. Gosselin C., De Serres G., Rouleau I., et al. Comparison of trip characteristics of children and adults with travel-acquired hepatitis A infection. Pediatr Infect Dis J 25 12 (2006) 1184-1186
24. Mutsch M., Spicher V.M., Gut C., et al. Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis 42 4 (2006) 490-497
25. Ciccozzi M., Tosti M.E., Gallo G., et al. Risk of hepatitis A infection following travel. J Viral Hepat 9 (2002) 460-465
26. Wilder-Smith A., and Memish Z. Meningococcal disease and travel. Int J Antimicrob Agents 21 2 (2003) 102-106
27. Centers for Disease Control and Prevention. Health information for international travel 2008 (2007), US Department of Health and Human Services, Public Health Service, Atlanta (GA)
28. Memish Z.A. Meningococcal disease and travel. Clin Infect Dis 34 (2002) 84-90
29. van de Beek D., de Gans J., Tunkel A.R., et al. Community-acquired bacterial meningitis in adults. N Engl J Med 354 (2006) 44-53
30. Riddle M.S., Sanders J.W., Putnam S.D., et al. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg 74 5 (2006) 891-900
31. Dupont H.L., Jiang Z.D., and Belkind-Gerson J. Treatment of traveler's diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol 5 4 (2007) 451-456
32. Taylor D.N., Sanchez J.L., and Candler W. Treatment of traveler's diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med 114 9 (1991) 731-734
33. DuPont H.L., Jiang Z.D., Okhuysen P.C., et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent traveler's diarrhea. Ann Intern Med 142 10 (2005) 805-812
34. Murphy G.S., Bodhidatta L., Echeverria P., et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med 118 8 (1993) 582-586
35. Khan W.A., Bennish M.L., Seas C., et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139. Lancet 348 9023 (1996) 296-300
36. Steffen R., Acar J., Walker E., et al. Cholera: assessing the risk to travellers and identifying methods of protection. Travel Med Infect Dis 1 2 (2003) 80-88
37. Steinberg E.B., Greene K.D., Bopp C.A., et al. Cholera in the United States, 1995-2000: trends at the end of the twentieth century. J Infect Dis 184 6 (2001) 799-802
38. Blackwell V., and Vega-Lopez F. Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. Br J Dermatol 145 3 (2001) 434-437
39. Jelinek T., Maiwald H., Nothdurft H.D., et al. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis 19 6 (1994) 1062-1066
40. Albanese G., Venturi C., and Galbiati G. Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy. Int J Dermatol 40 1 (2001) 67-71
41. Scarisbrick J.J., Chiodini P.L., Watson J., et al. Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis. Travel Med Infect Dis 4 1 (2006) 14-21
42. Antinori S., Gianelli E., Calattini S., et al. Cutaneous leishmaniasis: an increasing threat for travellers. Clin Microbiol Infect 11 5 (2005) 343-346
43. Steere A.C., Schoen R.T., and Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 107 5 (1987) 725-731
44. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 9 (2006) 1089-1134
45. Nadelman R.B., Nowakowski J., Fish D., et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 345 2 (2001) 79-84
46. Barnett E.D. Yellow fever: epidemiology and prevention. Clin Infect Dis 44 6 (2007) 850-856
47. Weir E., and Haider S. Yellow fever: readily prevented but difficult to treat. CMAJ 170 13 (2004) 1909-1910
48. Juckett G. Avian influenza: preparing for a pandemic. Am Fam Physician 74 5 (2006) 783-790
49. Cheung C.L., Rayner J.M., Smith G.J., et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 193 12 (2006) 1626-1629
50. Treanor J.J., Campbell J.D., Zangwill K.M., et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354 13 (2006) 1343-1351
51. Trypanosomiasis, African (African sleeping sickness). Centers for Disease Control and Prevention. Health information for international travel 2008 (2007), US Department of Health and Human Services, Public Health Service, Atlanta (GA)
52. Oscherwitz S.L. East African trypanosomiasis. J Travel Med 10 2 (2003) 141-143
53. Sinha A., Grace C., Alston W.K., et al. African trypanosomiasis in two travelers from the United States. Clin Infect Dis 29 4 (1999) 840-844
54. Braakman H.M., van de Molengraft F.J., Hubert W.W., et al. Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66 7 (2006) 1094-1096